학술논문

Safety and Sustained Efficacy of the Farnesoid X Receptor (FXR) Agonist Cilofexor Over a 96-Week Open-label Extension in Patients With PSC
Document Type
Article
Source
In: Clinical Gastroenterology and Hepatology. (Clinical Gastroenterology and Hepatology, June 2023, 21(6):1552-1560.e2)
Subject
Language
English
ISSN
15427714
15423565